Dapagliflozin and Metformin Hydrochloride

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 33342-409
  • Package NDC 33342-409-06
  • Package NDC 33342-409-07
  • Package NDC 33342-409-09
  • Package NDC 33342-409-10
  • Package NDC 33342-409-15
  • Application number ANDA211559
  • SPL ID 237ce7d1-f375-4c14-971d-a682fdccd6bf
  • SPL set ID 7d575ca8-9c1f-469d-a341-34daf2f036dd
  • UNII 1ULL0QJ8UC
  • UNII 786Z46389E
  • RxCUI 1593058
  • RxCUI 1593068
  • RxCUI 1593070
  • RxCUI 1593072

What the source publishes

Labeler
Macleods Pharmaceuticals Limited
Active ingredients
Dapagliflozin and Metformin Hydrochloride
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:33342-409_237ce7d1-f375-4c14-971d-a682fdccd6bf
{
  "name": "Dapagliflozin and Metformin Hydrochloride",
  "splId": "237ce7d1-f375-4c14-971d-a682fdccd6bf",
  "labels": [
    {
      "setId": "7d575ca8-9c1f-469d-a341-34daf2f036dd",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d575ca8-9c1f-469d-a341-34daf2f036dd",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7d575ca8-9c1f-469d-a341-34daf2f036dd"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Macleods Pharmaceuticals Limited",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "3 BLISTER PACK in 1 CARTON (33342-409-06)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (33342-409-66)",
      "package_ndc": "33342-409-06",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260406"
    },
    {
      "sample": false,
      "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-409-07)",
      "package_ndc": "33342-409-07",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260406"
    },
    {
      "sample": false,
      "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-409-09)",
      "package_ndc": "33342-409-09",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260406"
    },
    {
      "sample": false,
      "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-409-10)",
      "package_ndc": "33342-409-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260406"
    },
    {
      "sample": false,
      "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-409-15)",
      "package_ndc": "33342-409-15",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260406"
    }
  ],
  "productId": "33342-409_237ce7d1-f375-4c14-971d-a682fdccd6bf",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "33342-409",
  "deaSchedule": null,
  "genericName": "Dapagliflozin and Metformin Hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "DAPAGLIFLOZIN",
      "strength": "10 mg/1"
    },
    {
      "name": "METFORMIN HYDROCHLORIDE",
      "strength": "1000 mg/1"
    }
  ],
  "applicationNumber": "ANDA211559",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260406",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000187059",
      "N0000187058"
    ],
    "upc": [
      "0333342409096",
      "0333342406071",
      "0333342407153",
      "0333342406095",
      "0333342409102",
      "0333342408150",
      "0333342407092",
      "0333342406101",
      "0333342408075",
      "0333342407078",
      "0333342409072",
      "0333342406156",
      "0333342408105",
      "0333342409157",
      "0333342408099",
      "0333342407108"
    ],
    "unii": [
      "1ULL0QJ8UC",
      "786Z46389E"
    ],
    "rxcui": [
      "1593058",
      "1593068",
      "1593070",
      "1593072"
    ],
    "spl_set_id": [
      "7d575ca8-9c1f-469d-a341-34daf2f036dd"
    ],
    "pharm_class_epc": [
      "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Macleods Pharmaceuticals Limited"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:33342-409_237ce7d1-f375-4c14-971d-a682fdccd6bf"